Prediction of preeclampsia by combining serum histidine-rich glycoprotein and uterine artery doppler

American Journal of Hypertension

Volumn 25, Issue 12, 2012, Pages 1305-1310

  Bolin, Marie ^a,b   Wikström, Anna Karin ^a   Wiberg Itzel, Eva ^c   Olsson, Anna Karin ^d   Ringvall, Maria ^d   Sundström Poromaa, Inger ^a   Axelsson, Ove ^a   Thilaganathan, Basky ^e   Åkerud, Helena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b SUNDSVALL HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

blood pressure; histidine rich glycoprotein; hypertension; prediction; preeclampsia; uterine artery Doppler

Indexed keywords

GLYCOPROTEIN; HISTIDINE; HISTIDINE RICH GLYCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE ARTERY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROTEINS; PULSATILE FLOW; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER; UTERINE ARTERY;

EID: 84869218046     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2012.112     Document Type: Article

References (35)

1. Murphy DJ, Stirrat GM. Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy 2000; 19:221-231. (Pubitemid 30436489)
2. Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol 2000; 96:950-955.
3. Rolfo A, Many A, Racano A, Tal R, Tagliaferro A, Ietta F, Wang J, Post M, Caniggia I. Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS ONE 2010; 5:e13288.
4. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008; 52:873-880.
5. James JL, Whitley GS, Cartwright JE. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol 2010; 221:363-378.
6. Heilmann L, Rath W, Pollow K. Hemostatic abnormalities in patients with severe preeclampsia. Clin Appl Thromb Hemost 2007; 13:285-291. (Pubitemid 47000565)
7. Giguère Y, Charland M, Bujold E, Bernard N, Grenier S, Rousseau F, Lafond J, Légaré F, Forest JC. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem 2010; 56:361-375.
8. Lin S, Shimizu I, Suehara N, Nakayama M, Aono T. Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995; 85:760-765.
9. Harrington KF, Campbell S, Bewley S, Bower S. Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation. Eur J Obstet Gynecol Reprod Biol 1991; 42(Suppl):S14-S20.
10. Cetin I, Huppertz B, Burton G, Cuckle H, Gonen R, Lapaire O, Mandia L, Nicolaides K, Redman C, Soothill P, Spencer K, Thilaganathan B, Williams D, Meiri H. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 2011; 32(Suppl):S4-16.
11. Pedrosa AC, Matias A. Screening for pre-eclampsia: a systematic review of tests combining uterine artery Doppler with other markers. J Perinat Med 2011; 39:619-635.
12. Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 2011; 66:225-239.
13. Olsson AK, Larsson H, Dixelius J, Johansson I, Lee C, Oellig C, Björk I, Claesson-Welsh L. A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization. Cancer Res 2004; 64:599-605. (Pubitemid 38120899)
14. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3:1894-1904. (Pubitemid 41716577)
15. Poon IK, Patel KK, Davis DS, Parish CR, Hulett MD. Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood 2011; 117:2093-2101.
16. Blank M, Shoenfeld Y. Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems. Clin Rev Allergy Immunol 2008; 34:307-312.
17. Kårehed K, Wikström AK, Olsson AK, Larsson A, Olovsson M, Akerud H. Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia. Acta Obstet Gynecol Scand 2010; 89:131-139.
18. Bolin M, Akerud P, Hansson A, Akerud H. Histidine-rich glycoprotein as an early biomarker of preeclampsia. Am J Hypertens 2011; 24:496-501.
19. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21:9-23.
20. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179:80-86. (Pubitemid 28394477)
21. Williams VK, Griffiths AB, Carbone S, Hague WM. Fibrinogen concentration and factor VIII activity in women with preeclampsia. Hypertens Pregnancy 2007; 26:415-421. (Pubitemid 350232900)
22. Manten GT, Sikkema JM, Franx A, Hameeteman TM, Visser GH, de Groot PG, Voorbij HA. Increased high molecular weight fibrinogen in pre-eclampsia. Thromb Res 2003; 111:143-147. (Pubitemid 37532851)
23. Saigo K, Yoshida A, Ryo R, Yamaguchi N, Leung LL. Histidine-rich glycoprotein as a negative acute phase reactant. Am J Hematol 1990; 34:149-150. (Pubitemid 20180108)
24. Dixelius J, Olsson AK, Thulin A, Lee C, Johansson I, Claesson-Welsh L. Minimal active domain and mechanism of action of the angiogenesis inhibitor histidinerich glycoprotein. Cancer Res 2006; 66:2089-2097.
25. Lee C, Dixelius J, Thulin A, Kawamura H, Claesson-Welsh L, Olsson AK. Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions. Exp Cell Res 2006; 312:2547-2556. (Pubitemid 44036805)
26. Simantov R, Febbraio M, Crombie R, Asch AS, Nachman RL, Silverstein RL. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Invest 2001; 107:45-52. (Pubitemid 32047413)
27. Jespersen J, Gram J, Bach E. A sequential study of plasma histidine-rich glycoprotein and plasminogen in patients with acute myocardial infarction and deep vein thrombosis. Thromb Haemost 1984; 51:99-102. (Pubitemid 14159211)
28. Wickström K, Edelstam G, Löwbeer CH, Hansson LO, Siegbahn A. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest 2004; 64:31-40. (Pubitemid 38283207)
29. Leung LL. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest 1986; 77:1305-1311. (Pubitemid 16047154)
30. Leung LL, Harpel PC, Nachman RL, Rabellino EM. Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood 1983; 62:1016-1021. (Pubitemid 14237323)
31. Janes SL, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci 1994; 86:731-739. (Pubitemid 24181967)
32. Cnossen JS, ter Riet G, Mol BW, van der Post JA, Leeflang MM, Meads CA, Hyde C, Khan KS. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet Gynecol Scand 2009; 88:758-765.
33. Gómez O, Martínez JM, Figueras F, Del Río M, Borobio V, Puerto B, Coll O, Cararach V, Vanrell JA. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol 2005; 26:490-494. (Pubitemid 41634533)
34. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18:583-586. (Pubitemid 34063054)
35. Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia. Ultrasound Obstet Gynecol 2008; 32:133-137.